Download Your Cardio-HART Brochure Now
Ai powered ECG device: reduces the weighting list for Echocardiogram
I agree to receive marketing communications from MIAL Healthcare. I understand that I can opt out at any time.
What does the device do?
Cardio-HART(tm) is a breakthrough technology that creates a new class of medical device. It combines the diagnostic capabilities of a 12-Lead ECG, an eStethoscope and an Echocardiogram able to detect and diagnose ~93% of all common Cardiovascular Diseases (CVD) 1including heart failure (HF) and Valvular Heart Diseases (HVD), for use in point-of-care settings including primary care.
ECG: Standard 12-Lead ECG, AI reporting. Combines the diagnostic capabilities of ECG, eStethoscope and Echocardiography in one device. Direct replacement for ECG, swap-in/swap-out.
Vale Abnormalities: Reports structural and functional dysfunctions, similarly to Echocardiography, in the form of 14 findings that are disease equivalent to Echocardiography Echo-findings.
Cardiovascular Disease: Detects early onset of these CVDs and indicates severity for these CVDs
Ejection Fraction: Provide an accurate estimation of LVEF, similarly accurate to Bi-plane Simpson's Method.
Heart Failure:Indicates presence of heart failure, by type and severity, whether preserved [HFpEF], mild-reduced [HFmrEF], or reduced [HFrEF]. Indicates consideration of an NT-proBNP test.
Dr. Teresa Castiello
HFA facility member and current cardiology chair for the Royal Society of Medicine uses the Cardo-HART device in her private practice.
She is the recipient of the International Excellence Award for Cardiologist of the Year 2024, an honour bestowed by Fortuna Global, one of Asia’s largest jury-led excellence award programs.
